Frontlight ResearchEarly access
Trial site
Center for Psychiatry and Behavioral Medicine Inc
- 1running trial
- 6closed trials
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Autism1 trial
- Phase
- Phase 44 trials
- Phase 32 trials
- Phase 21 trial
- Status
- Completed5 trials
- Recruiting1 trial
- Withdrawn1 trial
- Lead sponsor
- Corium, Inc.2 trials
- Aardvark Therapeutics, Inc.1 trial
- Aytu BioPharma, Inc.1 trial
- Cingulate Therapeutics1 trial
- Otsuka Pharmaceutical Development & Commercialization, Inc.1 trial
- and 1 more
Running trials
Closed trials
Completed
A Study to Evaluate ARD-501 in Patients With Autism Spectrum Disorder
Completed
Phase 3 Efficacy and Safety Fixed-Dose Study in Pediatrics (6-17) With ADHD Using CTx-1301
Completed
A Safety/Tolerability and PK Study With Azstarys® in Children With ADHD
Completed
An Efficacy and Safety Study w/ Azstarys® in Children 4-12 Years of Age With ADHD
Completed
A Study of TAK-503 in Children and Teenagers With Attention Deficit Hyperactivity Disorder (ADHD)
Withdrawn
ADZENYS XR-ODT™ in Children (4 to <6 Years) Diagnosed With Attention-deficit/Hyperactivity Disorder
Site data: ClinicalTrials.govUpdated 15 Nov 2026